88 related articles for article (PubMed ID: 23266392)
1. Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.
Kohaar I; Porter-Gill P; Lenz P; Fu YP; Mumy A; Tang W; Apolo AB; Rothman N; Baris D; Schned AR; Ylaya K; Schwenn M; Johnson A; Jones M; Kida M; Silverman DT; Hewitt SM; Moore LE; Prokunina-Olsson L
J Natl Cancer Inst; 2013 Jan; 105(1):69-73. PubMed ID: 23266392
[TBL] [Abstract][Full Text] [Related]
2. A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer.
Morris MJ; Eisenberger MA; Pili R; Denmeade SR; Rathkopf D; Slovin SF; Farrelly J; Chudow JJ; Vincent M; Scher HI; Carducci MA
Ann Oncol; 2012 Oct; 23(10):2714-2719. PubMed ID: 22553195
[TBL] [Abstract][Full Text] [Related]
3. GPA: a statistical approach to prioritizing GWAS results by integrating pleiotropy and annotation.
Chung D; Yang C; Li C; Gelernter J; Zhao H
PLoS Genet; 2014 Nov; 10(11):e1004787. PubMed ID: 25393678
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study identifies multiple loci associated with bladder cancer risk.
Figueroa JD; Ye Y; Siddiq A; Garcia-Closas M; Chatterjee N; Prokunina-Olsson L; Cortessis VK; Kooperberg C; Cussenot O; Benhamou S; Prescott J; Porru S; Dinney CP; Malats N; Baris D; Purdue M; Jacobs EJ; Albanes D; Wang Z; Deng X; Chung CC; Tang W; Bas Bueno-de-Mesquita H; Trichopoulos D; Ljungberg B; Clavel-Chapelon F; Weiderpass E; Krogh V; Dorronsoro M; Travis R; Tjønneland A; Brenan P; Chang-Claude J; Riboli E; Conti D; Gago-Dominguez M; Stern MC; Pike MC; Van Den Berg D; Yuan JM; Hohensee C; Rodabough R; Cancel-Tassin G; Roupret M; Comperat E; Chen C; De Vivo I; Giovannucci E; Hunter DJ; Kraft P; Lindstrom S; Carta A; Pavanello S; Arici C; Mastrangelo G; Kamat AM; Lerner SP; Barton Grossman H; Lin J; Gu J; Pu X; Hutchinson A; Burdette L; Wheeler W; Kogevinas M; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Schwenn M; Karagas MR; Johnson A; Schned A; Armenti KR; Hosain GM; Andriole G; Grubb R; Black A; Ryan Diver W; Gapstur SM; Weinstein SJ; Virtamo J; Haiman CA; Landi MT; Caporaso N; Fraumeni JF; Vineis P; Wu X; Silverman DT; Chanock S; Rothman N
Hum Mol Genet; 2014 Mar; 23(5):1387-98. PubMed ID: 24163127
[TBL] [Abstract][Full Text] [Related]
5. Significance of PSCA as a novel prognostic marker and therapeutic target for cancer.
Nayerpour Dizaj T; Doustmihan A; Sadeghzadeh Oskouei B; Akbari M; Jaymand M; Mazloomi M; Jahanban-Esfahlan R
Cancer Cell Int; 2024 Apr; 24(1):135. PubMed ID: 38627732
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.
Koutros S; Kiemeney LA; Pal Choudhury P; Milne RL; Lopez de Maturana E; Ye Y; Joseph V; Florez-Vargas O; Dyrskjøt L; Figueroa J; Dutta D; Giles GG; Hildebrandt MAT; Offit K; Kogevinas M; Weiderpass E; McCullough ML; Freedman ND; Albanes D; Kooperberg C; Cortessis VK; Karagas MR; Johnson A; Schwenn MR; Baris D; Furberg H; Bajorin DF; Cussenot O; Cancel-Tassin G; Benhamou S; Kraft P; Porru S; Carta A; Bishop T; Southey MC; Matullo G; Fletcher T; Kumar R; Taylor JA; Lamy P; Prip F; Kalisz M; Weinstein SJ; Hengstler JG; Selinski S; Harland M; Teo M; Kiltie AE; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Schned A; Lenz P; Riboli E; Brennan P; Tjønneland A; Otto T; Ovsiannikov D; Volkert F; Vermeulen SH; Aben KK; Galesloot TE; Turman C; De Vivo I; Giovannucci E; Hunter DJ; Hohensee C; Hunt R; Patel AV; Huang WY; Thorleifsson G; Gago-Dominguez M; Amiano P; Golka K; Stern MC; ; Yan W; Liu J; Li SA; Katta S; Hutchinson A; Hicks B; Wheeler WA; Purdue MP; McGlynn KA; Kitahara CM; Haiman CA; Greene MH; Rafnar T; Chatterjee N; Chanock SJ; Wu X; Real FX; Silverman DT; Garcia-Closas M; Stefansson K; Prokunina-Olsson L; Malats N; Rothman N
Eur Urol; 2023 Jul; 84(1):127-137. PubMed ID: 37210288
[TBL] [Abstract][Full Text] [Related]
7. Mediation by differential DNA methylation of known associations between single nucleotide polymorphisms and bladder cancer risk.
Jordahl KM; Phipps AI; Randolph TW; Tinker LF; Nassir R; Hou L; Anderson GL; Kelsey KT; White E; Bhatti P
BMC Med Genet; 2020 Nov; 21(1):228. PubMed ID: 33213418
[TBL] [Abstract][Full Text] [Related]
8. Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer.
Selinski S; Blaszkewicz M; Ickstadt K; Gerullis H; Otto T; Roth E; Volkert F; Ovsiannikov D; Moormann O; Banfi G; Nyirady P; Vermeulen SH; Garcia-Closas M; Figueroa JD; Johnson A; Karagas MR; Kogevinas M; Malats N; Schwenn M; Silverman DT; Koutros S; Rothman N; Kiemeney LA; Hengstler JG; Golka K
Carcinogenesis; 2017 Dec; 38(12):1167-1179. PubMed ID: 29028944
[TBL] [Abstract][Full Text] [Related]
9. Association of high-evidence gastric cancer susceptibility loci and somatic gene expression levels with survival.
Sung H; Hu N; Yang HH; Giffen CA; Zhu B; Song L; Su H; Wang C; Parisi DM; Goldstein AM; Taylor PR; Hyland PL
Carcinogenesis; 2017 Oct; 38(11):1119-1128. PubMed ID: 29028942
[TBL] [Abstract][Full Text] [Related]
10. A Multiple Interaction Analysis Reveals ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Complex Interaction with Other Candidate Gene Variations.
Rai R; Kim JJ; Misra S; Kumar A; Mittal B
Int J Mol Sci; 2015 Nov; 16(12):28038-49. PubMed ID: 26602921
[TBL] [Abstract][Full Text] [Related]
11. Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer.
Li M; Yu X; Cheng L; Huang Y; Weng G
Int J Clin Exp Med; 2015; 8(8):13259-66. PubMed ID: 26550251
[TBL] [Abstract][Full Text] [Related]
12. PSCA rs2294008 Polymorphism with Increased Risk of Cancer.
Geng P; Li J; Wang N; Ou J; Xie G; Liu C; Zhao X; Xiang L; Liao Y; Liang H
PLoS One; 2015; 10(8):e0136269. PubMed ID: 26308216
[TBL] [Abstract][Full Text] [Related]
13. Association between PSCA mRNA expression levels and rs2294008 polymorphism in transitional cell cancer of the bladder.
Zheng K; Chen Z; Tian Y; Hao G
Oncol Lett; 2015 Feb; 9(2):557-562. PubMed ID: 25624885
[TBL] [Abstract][Full Text] [Related]
14. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.
Fu YP; Kohaar I; Moore LE; Lenz P; Figueroa JD; Tang W; Porter-Gill P; Chatterjee N; Scott-Johnson A; Garcia-Closas M; Muchmore B; Baris D; Paquin A; Ylaya K; Schwenn M; Apolo AB; Karagas MR; Tarway M; Johnson A; Mumy A; Schned A; Guedez L; Jones MA; Kida M; Hosain GM; Malats N; Kogevinas M; Tardon A; Serra C; Carrato A; Garcia-Closas R; Lloreta J; Wu X; Purdue M; Andriole GL; Grubb RL; Black A; Landi MT; Caporaso NE; Vineis P; Siddiq A; Bueno-de-Mesquita HB; Trichopoulos D; Ljungberg B; Severi G; Weiderpass E; Krogh V; Dorronsoro M; Travis RC; Tjønneland A; Brennan P; Chang-Claude J; Riboli E; Prescott J; Chen C; De Vivo I; Govannucci E; Hunter D; Kraft P; Lindstrom S; Gapstur SM; Jacobs EJ; Diver WR; Albanes D; Weinstein SJ; Virtamo J; Kooperberg C; Hohensee C; Rodabough RJ; Cortessis VK; Conti DV; Gago-Dominguez M; Stern MC; Pike MC; Van Den Berg D; Yuan JM; Haiman CA; Cussenot O; Cancel-Tassin G; Roupret M; Comperat E; Porru S; Carta A; Pavanello S; Arici C; Mastrangelo G; Grossman HB; Wang Z; Deng X; Chung CC; Hutchinson A; Burdette L; Wheeler W; Fraumeni J; Chanock SJ; Hewitt SM; Silverman DT; Rothman N; Prokunina-Olsson L
Cancer Res; 2014 Oct; 74(20):5808-18. PubMed ID: 25320178
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation levels at chromosome 8q24 in peripheral blood are associated with 8q24 cancer susceptibility loci.
Barry KH; Moore LE; Sampson J; Yan L; Meyer A; Oler AJ; Chung CC; Wang Z; Yeager M; Amundadottir L; Berndt SI
Cancer Prev Res (Phila); 2014 Dec; 7(12):1282-92. PubMed ID: 25315430
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapies in urothelial carcinoma.
Ghosh M; Brancato SJ; Agarwal PK; Apolo AB
Curr Opin Oncol; 2014 May; 26(3):305-20. PubMed ID: 24685646
[TBL] [Abstract][Full Text] [Related]
17. Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms?
Dudek AM; Grotenhuis AJ; Vermeulen SH; Kiemeney LA; Verhaegh GW
Int J Mol Sci; 2013 Jun; 14(6):12346-66. PubMed ID: 23752272
[TBL] [Abstract][Full Text] [Related]
18. Targeting molecular aberrations in urothelial carcinoma: are we almost there?
Apolo AB; Kwiatkowski DJ
Am Soc Clin Oncol Educ Book; 2013; ():195-9. PubMed ID: 23714499
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
